Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lorazepam
Drug ID BADD_D01318
Description Lorazepam is a short-acting and rapidly cleared benzodiazepine used commonly as a sedative and anxiolytic.[A957] It was developed by DJ Richards, presented and marketed initially by Wyeth Pharmaceuticals in the USA in 1977. The first historic FDA label approval is reported in 1985 by the company Mutual Pharm.[L5095]
Indications and Usage For the management of anxiety disorders, and for treatment of status epilepticus.
Marketing Status Prescription; Discontinued
ATC Code N05BA06
DrugBank ID DB00186
KEGG ID D00365
MeSH ID D008140
PubChem ID 3958
TTD Drug ID D0E0OG
NDC Product Code 55700-778; 0904-6009; 55289-402; 53002-7721; 52427-663; 0641-6046; 0641-6051; 72572-380; 0409-6778; 60687-638; 68071-5068; 0591-0242; 60687-401; 54348-049; 53002-5291; 69315-905; 76329-8261; 70518-2239; 68788-7480; 52696-0002; 0093-3425; 53002-5290; 61919-607; 13107-085; 0641-6048; 70518-2442; 55289-487; 68071-5137; 51927-1005; 0641-6207; 71610-600; 72166-001; 54348-028; 0641-6003; 71610-122; 67296-1332; 0591-0241; 43063-048; 43063-057; 55154-7976; 0409-6779; 0904-6007; 69315-906; 63629-8185; 0641-6047; 12828-0025; 67296-1629; 71610-178; 55700-745; 70518-1520; 68788-7428; 0641-6049; 65162-017; 70518-0486; 71610-255; 68071-2666; 0641-6001; 50090-0273; 70518-3225; 0409-1985; 76420-296; 45865-499; 67544-142; 0615-8077; 65162-018; 0641-6044; 48087-0076; 65162-015; 50090-0272; 50090-4001; 0409-1539; 68071-5084; 51927-0195; 0409-6780; 71610-199; 52427-667; 0615-8075; 72789-197; 50090-5508; 67296-1622; 60687-355; 67763-101; 50383-705; 68071-5022; 0641-6000; 49452-4140; 71205-228; 58118-1095; 63187-536; 68788-7533; 71335-0655; 13107-084; 13107-083; 70518-3188; 71205-166; 61919-062; 63629-2953; 68071-5061; 68071-5048; 71335-0329; 58118-1096; 70518-0445; 0591-0240; 0641-6045; 71610-229; 0641-6050; 62991-1682; 69315-904; 71335-1694; 68071-4882; 0054-3532; 63187-576; 71554-009; 53002-6290; 50090-4191; 68071-3096; 58118-0904; 60760-516; 50090-4157; 50090-5509; 60687-627; 71335-1467; 0187-0065; 72789-236; 17856-2059; 52427-661; 72789-226; 0093-3426; 50090-5081; 43353-255; 68071-4918; 71610-008; 0641-6002; 68071-3242; 71335-1138; 70518-2268; 68071-3227; 0093-3427; 68788-7355; 68071-2662; 63275-9979; 0121-0770; 0615-8076; 67544-191; 38779-0927; 0395-8161; 68071-4916; 70518-2186; 71610-225; 55154-7975; 70518-0275; 52427-658; 68071-5250; 50090-2810; 17478-040; 60687-649; 65162-687; 0187-0063; 51552-0729; 64330-020; 71205-235; 68071-3121; 67296-0143; 50090-3462; 67544-261; 17856-3532; 0904-6008; 57218-950; 0187-0064
Synonyms Lorazepam | Ativan | Orfidal Wyeth | Wyeth, Orfidal | Témesta | Tolid | Donix | Duralozam | Durazolam | Idalprem | Laubeel | Lorazep Von Ct | Von Ct, Lorazep | Lorazepam Medical | Medical, Lorazepam | Lorazepam-Neuraxpharm | Lorazepam Neuraxpharm | Lorazepam-Ratiopharm | Lorazepam Ratiopharm | Novo-Lorazem | Novo Lorazem | Nu-Loraz | Nu Loraz | Sedicepan | Sinestron | WY-4036 | WY 4036 | WY4036 | Apo-Lorazepam | Apo Lorazepam | Somagerol | Temesta
Chemical Information
Molecular Formula C15H10Cl2N2O2
CAS Registry Number 846-49-1
SMILES C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Unevaluable event08.01.03.051--Not Available
Heparin-induced thrombocytopenia24.01.01.020; 10.02.01.007; 01.08.01.0040.000336%Not Available
Cystitis noninfective20.03.02.001--
Self injurious behaviour19.12.01.0050.000336%Not Available
Bone marrow failure01.03.03.005--
Dermatillomania23.03.11.011; 19.06.05.0050.000134%Not Available
Substance abuse19.07.02.0060.000134%Not Available
Treatment failure08.06.01.017--Not Available
Liver injury12.01.02.003; 09.01.07.0220.000336%Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.004--
Acute kidney injury20.01.03.0160.001409%
Slow speech19.19.02.004; 17.02.08.0160.001141%Not Available
Drug-induced liver injury12.03.01.044; 09.01.07.0230.000738%Not Available
Myocardial necrosis marker increased13.04.01.0130.000134%Not Available
Liver function test increased13.03.01.044--Not Available
Alcohol interaction08.06.03.0030.000940%Not Available
Coeliac disease10.04.04.012; 14.02.01.007; 07.17.01.0080.000201%Not Available
Confabulation19.10.03.0090.000134%Not Available
Drop attacks17.05.02.016; 15.05.04.0180.000403%Not Available
Maternal drugs affecting foetus18.03.03.009; 12.03.03.0060.000134%Not Available
Posturing19.11.03.008; 17.01.02.0240.000134%Not Available
Pupil fixed17.02.11.008; 06.05.03.0120.000134%Not Available
Simple partial seizures17.12.05.0010.000134%Not Available
Aspiration bronchial13.19.03.0030.000134%Not Available
Troponin T increased13.04.01.0150.000134%
Sopor19.02.04.002; 17.02.04.0210.018187%Not Available
Analgesic drug level increased13.17.01.0140.000268%Not Available
Cerebellar haematoma24.07.04.022; 17.08.01.0450.000053%Not Available
Toxicologic test abnormal13.17.02.0140.000035%Not Available
Stress cardiomyopathy24.04.04.026; 02.04.01.0120.000671%Not Available
The 15th Page    First    Pre   15 16    Next   Last    Total 16 Pages